Breaking News Instant updates and real-time market news.

2020-11-17 08:04:31 EIGR Eiger BioPharmaceuticals $10.95 / +0.37 (+3.50%) 08:04 11/17/20 11/17 08:04 11/17/20 08:04	Eiger announces oral presentation of Phase 2 LIFT results Eiger BioPharmaceuticals announced a late-breaker oral presentation of Phase 2 LIFT results at The Liver Meeting Digital Experience 2020. Week 48 end of study results were presented. Peginterferon lambda is a first-in-class type III interferon in development for hepatitis delta virus (HDV) infection, the most severe form of human viral hepatitis. The LIFT study was conducted within the National Institutes of Health (NIH) at the National Institute of Diabetes and Digestive and Kidney Diseases, or NIDDK, and was led by Christopher Koh, MD, Principal Investigator at the National Institute of Diabetes and Digestive and Kidney Diseases. LIFT is a Phase 2, open-label study of 26 adult patients with chronic HDV treated with Lambda 180 mcg once weekly in combination with Lonafarnib 50 mg boosted with ritonavir 100 mg twice daily for 24 weeks followed by 24 weeks of post-treatment follow-up.	20 Nov

2020-11-17 08:04:31

EIGR

Eiger BioPharmaceuticals

$10.95 / +0.37 (+3.50%)

08:04

11/17/20

11/17

08:04

11/17/20

08:04

Eiger announces oral presentation of Phase 2 LIFT results

Eiger BioPharmaceuticals announced a late-breaker oral presentation of Phase 2 LIFT results at The Liver Meeting Digital Experience 2020. Week 48 end of study results were presented. Peginterferon lambda is a first-in-class type III interferon in development for hepatitis delta virus (HDV) infection, the most severe form of human viral hepatitis. The LIFT study was conducted within the National Institutes of Health (NIH) at the National Institute of Diabetes and Digestive and Kidney Diseases, or NIDDK, and was led by Christopher Koh, MD, Principal Investigator at the National Institute of Diabetes and Digestive and Kidney Diseases. LIFT is a Phase 2, open-label study of 26 adult patients with chronic HDV treated with Lambda 180 mcg once weekly in combination with Lonafarnib 50 mg boosted with ritonavir 100 mg twice daily for 24 weeks followed by 24 weeks of post-treatment follow-up.

20
Nov

TODAY'S FREE FLY STORIES

Recommendations	Orange price target lowered to EUR 12.50 from EUR 13.60 at JPMorgan » 12:26 01/15/21 01/15 12:26 01/15/21 12:26 ORAN Orange $11.84 / -0.33 (-2.71%) JPMorgan analyst Akhil… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals ORAN Orange $11.84 / -0.33 (-2.71%) 12/03/20 Orange plans takeover bid on shares of Orange Belgium not owned 11/25/20 Orange denies working on any project relating to Atos takeover 11/23/20 Orange, AWS in strategic collaboration pact for customers' cloud innovation 10/01/20 Orange Business Services to reorganize its healthcare entities ORAN Orange $11.84 / -0.33 (-2.71%) 12/08/20 JPMorgan Orange price target raised to EUR 13.60 from EUR 13 at JPMorgan 10/27/20 Morgan Stanley Orange SA upgraded to Equal Weight from Underweight at Morgan Stanley 10/19/20 Berenberg Orange SA price target lowered to EUR 11.50 from EUR 12.50 at Berenberg 09/14/20 Oddo BHF Orange SA upgraded to Buy from Neutral at Oddo BHF ORAN Orange $11.84 / -0.33 (-2.71%) 10/08/20 Orange, Proximus to replace Huawei mobile gear with Nokia kit, Reuters says 10/08/20 Orange, Proximus to replace Huawei gear with Nokia equipment, Reuters says
Recommendations	Merlin Properties price target lowered to EUR 9 from EUR 9.50 at JPMorgan » 12:25 01/15/21 01/15 12:25 01/15/21 12:25 MRPRF Merlin Properties $0.00 / + (+0.00%) JPMorgan analyst Neil… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research MRPRF Merlin Properties $0.00 / + (+0.00%) 11/06/20 UBS Merlin Properties price target lowered to EUR 9 from EUR 14.50 at UBS 09/03/20 Morgan Stanley Merlin Properties downgraded to Equal Weight from Overweight at Morgan Stanley 08/03/20 Barclays Merlin Properties price target raised to EUR 8.90 from EUR 8.80 at Barclays 06/08/20 Goldman Sachs Merlin Properties downgraded to Sell from Neutral at Goldman Sachs
Recommendations	Klepierre price target lowered to EUR 20 from EUR 22 at JPMorgan » 12:25 01/15/21 01/15 12:25 01/15/21 12:25 KLPEF Klepierre $0.00 / + (+0.00%) JPMorgan analyst Neil… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research KLPEF Klepierre $0.00 / + (+0.00%) 12/10/20 Goldman Sachs Klepierre upgraded to Neutral from Sell at Goldman Sachs 11/20/20 RBC Capital Klepierre price target raised to EUR 25 from EUR 23 at RBC Capital 11/09/20 HSBC Klepierre upgraded to Buy from Hold at HSBC 10/22/20 UBS Klepierre price target lowered to EUR 10 from EUR 18 at UBS
Options	PG&E call volume above normal and directionally bullish » 12:25 01/15/21 01/15 12:25 01/15/21 12:25 PCG PG&E $12.30 / +0.465 (+3.93%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options PCG PG&E $12.30 / +0.465 (+3.93%) 01/05/21 FirstEnergy appoints Hyun Park as Chief Legal Officer 12/15/20 Willdan Group awarded $10M energy efficiency program from PG&E 12/03/20 PG&E says CPUC approves 'most aspects' of 2020-22 general rate case 11/18/20 CMS Energy CEO Patti Poppe to leave, Garrick Rochow to succeed PCG PG&E $12.30 / +0.465 (+3.93%) 01/06/21 Wells Fargo Wells Fargo says buy CenterPoint Energy, sell FirstEnergy 01/06/21 Wells Fargo PG&E downgraded to Underweight from Equal Weight at Wells Fargo 11/18/20 Barclays PG&E price target raised to $14 from $13 at Barclays 11/12/20 Wolfe Research PG&E upgraded to Outperform from Peer Perform at Wolfe Research PCG PG&E $12.30 / +0.465 (+3.93%) 10/29/20 PG&E sees FY21 core EPS 95c-$1.05, consensus $1.20 10/29/20 PG&E sees FY20 core EPS $1.60-$1.63, consensus $1.78 10/29/20 PG&E reports Q3 adjusted EPS 22c, consensus 26c 07/30/20 PG&E sees FY21 core EPS 95c-$1.05, consensus $1.66 26 Jun PCG PG&E $12.30 / +0.465 (+3.93%) 10/12/20 Judge orders PG&E to explain 'role in the ignition' of Zogg Fire, Bloomberg says 10/11/20 PG&E may cut power this week as CA fire risk returns, Bloomberg reports 09/28/20 PG&E says no indications lines started recent fires, Bloomberg reports 07/16/20 CA investigators say PG&E power lines ignited Kincade fire, Bloomberg says PCG PG&E $12.30 / +0.465 (+3.93%) 10/12/20 Fly Intel: Pre-market Movers 07/27/20 Tapestry, Biogen upgrades among today's top calls on Wall Street PCG PG&E $12.30 / +0.465 (+3.93%) 09:55 Today Early notable gainers among liquid option names on January 15th 11/18/20 Early notable gainers among liquid option names on November 18th 11/17/20 Early notable gainers among liquid option names on November 17th 11/12/20 Early notable gainers among liquid option names on November 12th
Recommendations	Hammerson price target lowered to 25 GBp from 30 GBp at JPMorgan » 12:24 01/15/21 01/15 12:24 01/15/21 12:24 HMSNF Hammerson $0.00 / + (+0.00%) JPMorgan analyst Neil… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research HMSNF Hammerson $0.00 / + (+0.00%) 12/14/20 Peel Hunt Hammerson upgraded to Hold from Reduce at Peel Hunt 11/06/20 Fly Intel: Top five analyst initiations 11/06/20 Morgan Stanley Hammerson resumed with an Equal Weight at Morgan Stanley 10/29/20 Stifel Hammerson price target lowered to 20 GBp from 60 GBp at Stifel

Recommendations	Galp Energia price target lowered to EUR 11 from EUR 11.50 at JPMorgan » 12:24 01/15/21 01/15 12:24 01/15/21 12:24 GLPEY Galp Energia $0.00 / + (+0.00%) JPMorgan analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research GLPEY Galp Energia $0.00 / + (+0.00%) 01/14/21 Credit Suisse Galp Energia price target lowered to EUR 13 from EUR 13.40 at Credit Suisse 01/14/21 Societe Generale Societe Generale downgrades three EU oil & gas names after strong performances 01/14/21 Societe Generale Galp Energia downgraded to Hold from Buy at Societe Generale 01/11/21 Morgan Stanley Galp Energia price target raised to EUR 10.20 from EUR 9.50 at Morgan Stanley
Recommendations	Salvatore Ferragamo price target lowered to EUR 14 from EUR 15.50 at JPMorgan » 12:24 01/15/21 01/15 12:24 01/15/21 12:24 SFRGY Salvatore Ferragamo $0.00 / + (+0.00%) JPMorgan analyst Melanie… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research SFRGY Salvatore Ferragamo $0.00 / + (+0.00%) 12/07/20 UBS Salvatore Ferragamo price target raised to EUR 15 from EUR 12.30 at UBS 12/03/20 Goldman Sachs Salvatore Ferragamo downgraded to Neutral from Buy at Goldman Sachs 11/16/20 Morgan Stanley Salvatore Ferragamo price target raised to EUR 13.70 at Morgan Stanley 10/28/20 UBS Salvatore Ferragamo price target raised to EUR 12.30 from EUR 12.20 at UBS
Recommendations	Total price target raised to EUR 46 from EUR 44 at JPMorgan » 12:23 01/15/21 01/15 12:23 01/15/21 12:23 TOT Total $44.51 / -1.46 (-3.18%) JPMorgan analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals TOT Total $44.51 / -1.46 (-3.18%) 01/14/21 Apache announces fourth oil discovery at Keskesi East-1 Well 12/21/20 Clean Energy, Total announce MOU to create 50/50 RNG joint venture 12/10/20 S&P Global WIM used for first LNG futures trade between Glencore, Total 11/17/20 Sempra Energy joint venture reaches FID for LNG export project TOT Total $44.51 / -1.46 (-3.18%) 01/14/21 Societe Generale Societe Generale downgrades three EU oil & gas names after strong performances 01/13/21 Credit Suisse Total price target raised to EUR 41.50 from EUR 39 at Credit Suisse 01/11/21 Mizuho Total initiated with a Neutral at Mizuho 01/11/21 Morgan Stanley Total price target raised to EUR 44 from EUR 37.70 at Morgan Stanley TOT Total $44.51 / -1.46 (-3.18%) 01/05/21 Saudi Arabia, Russia reach oil compromise, WSJ reports 01/05/21 OPEC+ reaches deal to hold oil output broadly steady, Bloomberg says 12/03/20 OPEC, allies agree to output boost of 500,000 barrels a day,WSJ reports 12/03/20 OPEC+ agrees on modest oil output increase from January, Reuters says
Recommendations	Thales price target raised to EUR 97 from EUR 95 at JPMorgan » 12:22 01/15/21 01/15 12:22 01/15/21 12:22 THLLY Thales $0.00 / + (+0.00%) JPMorgan analyst David… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research THLLY Thales $0.00 / + (+0.00%) 01/07/21 JPMorgan Thales price target raised to EUR 95 from EUR 91 at JPMorgan 11/23/20 Morgan Stanley Thales price target raised to EUR 69 from EUR 62 at Morgan Stanley 11/13/20 JPMorgan Thales price target raised to EUR 91 from EUR 87 at JPMorgan 11/06/20 Credit Suisse Thales upgraded to Outperform from Neutral at Credit Suisse
Syndicate	Playtika opens at $33.40, IPO priced at $27 per share 12:22 01/15/21 01/15 12:22 01/15/21 12:22 PLTK Playtika $0.00 / + (+0.00%) ShowHide Related Items >><< Syndicate 15 Jan

Recommendations	Taylor Wimpey price target raised to 160 GBp from 150 GBp at JPMorgan » 12:22 01/15/21 01/15 12:22 01/15/21 12:22 TWODF Taylor Wimpey $0.00 / + (+0.00%) JPMorgan analyst Rajesh… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research TWODF Taylor Wimpey $0.00 / + (+0.00%) 01/11/21 Morgan Stanley Taylor Wimpey price target raised to 180 GBp from 165 GBp at Morgan Stanley 12/07/20 Deutsche Bank Taylor Wimpey upgraded to Buy from Hold at Deutsche Bank 11/17/20 UBS Taylor Wimpey price target raised to 210 GBp from 175 GBp at UBS 11/10/20 Barclays Taylor Wimpey price target raised to 160 GBp from 125 GBp at Barclays
Recommendations	Segro price target raised to 910 GBp from 880 GBp at JPMorgan » 12:21 01/15/21 01/15 12:21 01/15/21 12:21 SEGXF Segro / + JPMorgan analyst Neil… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research SEGXF Segro / + 12/09/20 Jefferies Segro price target raised to 945 GBp from 925 GBp at Jefferies 12/09/20 Stifel Segro upgraded to Buy from Hold at Stifel 11/05/20 Peel Hunt Segro upgraded to Hold from Reduce at Peel Hunt 09/10/20 UBS Segro price target raised to 975 GBp from 900 GBp at UBS
Recommendations	Mirati Therapeutics price target lowered to $257 from $265 at H.C. Wainwright » 12:21 01/15/21 01/15 12:21 01/15/21 12:21 MRTX Mirati Therapeutics $215.25 / +1.39 (+0.65%) H.C. Wainwright analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly MRTX Mirati Therapeutics $215.25 / +1.39 (+0.65%) 10/25/20 Mirati reports preliminary results from mutant KRAS selective inhibitor programs 09/18/20 Mirati Therapeutics presents Phase 2 sitravatinib/nivolumab data at ESMO 09/17/20 Mirati Therapeutics, Boehringer collaborate on BI 1701963/MRTX849 combination 08/13/20 Mirati Therapeutics partners with Strata Oncology for patient enrollment MRTX Mirati Therapeutics $215.25 / +1.39 (+0.65%) 12/08/20 JMP Securities Mirati Therapeutics initiated with a Market Perform at JMP Securities 11/17/20 BofA Mirati Therapeutics downgraded to Underperform from Neutral at BofA 11/10/20 Guggenheim Mirati Therapeutics downgraded to Neutral from Buy at Guggenheim 11/10/20 Jefferies Mirati Therapeutics downgraded to Hold from Buy at Jefferies MRTX Mirati Therapeutics $215.25 / +1.39 (+0.65%) 11/04/20 Mirati Therapeutics reports Q3 EPS ($1.96), consensus ($1.97) 08/06/20 Mirati Therapeutics reports Q2 EPS ($1.89), consensus ($2.09) 28 Oct MRTX Mirati Therapeutics $215.25 / +1.39 (+0.65%) 10/26/20 Fly Intel: After-Hours Movers 10/26/20 Fly Intel: Wall Street's top stories for Monday 10/26/20 Fly Intel: Wall Street's top stories at midday
Recommendations	Royal Dutch Shell price target raised to 1,800 GBp from 1,700 GBp at JPMorgan » 12:21 01/15/21 01/15 12:21 01/15/21 12:21 RDS.A Royal Dutch Shell $40.34 / -1.31 (-3.15%) , RDS.B Royal Dutch Shell $38.36 / -1.4 (-3.52%) JPMorgan analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events RDS.A RDS.B RDS.A Royal Dutch Shell $40.34 / -1.31 (-3.15%) 01/04/21 Royal Dutch Shell designates Netherlands as EU Home Member State 12/15/20 H2Accelerate participants collaborate for hydrogen trucking roll-out 10/29/20 Royal Dutch Shell announces dividend per share growth by around 4% to 16.65c 10/29/20 Royal Dutch Shell increases quarterly dividend to 16.65c per share RDS.B Royal Dutch Shell $38.36 / -1.4 (-3.52%) 01/04/21 Royal Dutch Shell designates Netherlands as EU Home Member State 12/15/20 H2Accelerate participants collaborate for hydrogen trucking roll-out 10/29/20 Royal Dutch Shell announces dividend per share growth by around 4% to 16.65c 10/29/20 Royal Dutch Shell increases quarterly dividend to 16.65c per share RDS.A RDS.B RDS.A Royal Dutch Shell $40.34 / -1.31 (-3.15%) 01/14/21 Societe Generale Societe Generale downgrades three EU oil & gas names after strong performances 01/14/21 Societe Generale Royal Dutch Shell downgraded to Hold from Buy at Societe Generale 01/14/21 Scotiabank Royal Dutch Shell downgraded to Underperform from Outperform at Scotiabank 01/11/21 Mizuho Royal Dutch Shell initiated with a Buy at Mizuho RDS.B Royal Dutch Shell $38.36 / -1.4 (-3.52%) 12/23/20 MKM Partners Royal Dutch Shell initiated with a Buy at MKM Partners 12/22/20 MKM Partners Royal Dutch Shell initiated with a Buy at MKM Partners 12/15/20 Wells Fargo Wells Fargo says Buy Exxon Mobil, Sell Murphy Oil in Oil & Gas ratings shake-up 12/09/20 Berenberg Royal Dutch Shell price target raised to 1,570 GBp from 1,450 GBp at Berenberg RDS.A RDS.B RDS.A Royal Dutch Shell $40.34 / -1.31 (-3.15%) 10/29/20 Royal Dutch Shell reports Q3 basic EPS 6c, consensus (2c) 07/30/20 Royal Dutch Shell reports Q2 EPS ($2.33), consensus (26c) RDS.B Royal Dutch Shell $38.36 / -1.4 (-3.52%) 10/29/20 Royal Dutch Shell reports Q3 basic EPS 6c, consensus (2c) RDS.A RDS.B RDS.A Royal Dutch Shell $40.34 / -1.31 (-3.15%) 01/05/21 Saudi Arabia, Russia reach oil compromise, WSJ reports 01/05/21 OPEC+ reaches deal to hold oil output broadly steady, Bloomberg says 12/03/20 OPEC, allies agree to output boost of 500,000 barrels a day,WSJ reports 12/03/20 OPEC+ agrees on modest oil output increase from January, Reuters says RDS.B Royal Dutch Shell $38.36 / -1.4 (-3.52%) 12/03/20 OPEC, allies nearing deal for small production boost, WSJ reports 11/23/20 Shell weighs shutting down Convent refinery next week, Reuters says 10/08/20 OPEC lowers long-term forecast for oil demand growth, CNBC reports 09/21/20 Royal Dutch Shell seeks to cut 40% off cost of oil, gas production, Reuters says RDS.A RDS.B RDS.A Royal Dutch Shell $40.34 / -1.31 (-3.15%) 09/30/20 Fly Intel: Wall Street's top stories for Wednesday RDS.B Royal Dutch Shell $38.36 / -1.4 (-3.52%) 09/30/20 Fly Intel: Wall Street's top stories for Wednesday 02/04/21 Royal Dutch Shell - RDS.B 02/04/21 Royal Dutch Shell - RDS.A
Conference/Events	JPMorgan healthcare analysts to hold an analyst/industry conference call » 12:21 01/15/21 01/15 12:21 01/15/21 12:21 Healthcare Analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial

Recommendations	Repsol price target raised to EUR 8.50 from EUR 8 at JPMorgan » 12:20 01/15/21 01/15 12:20 01/15/21 12:20 REPYY Repsol $0.00 / + (+0.00%) JPMorgan analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research REPYY Repsol $0.00 / + (+0.00%) 01/14/21 Credit Suisse Repsol price target raised to EUR 10 from EUR 9.50 at Credit Suisse 01/14/21 Societe Generale Societe Generale downgrades three EU oil & gas names after strong performances 01/11/21 Morgan Stanley Repsol price target raised to EUR 8.55 from EUR 7.50 at Morgan Stanley 12/07/20 Morgan Stanley Repsol downgraded to Underweight from Equal Weight at Morgan Stanley
Hot Stocks	Citi says there's 'certainly' a need for more stimulus » 12:20 01/15/21 01/15 12:20 01/15/21 12:20 C Citi $64.69 / -4.34 (-6.29%) Says large enough… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options C Citi $64.69 / -4.34 (-6.29%) 12:03 Today Citi sees value in simplifying company 11:54 Today Citi sees peak U.S. loss rates in 1H22 11:47 Today Citi says reserve release reflects economic outlook 11:37 Today Citi plans to resume buybacks in Q1 C Citi $64.69 / -4.34 (-6.29%) 01/12/21 UBS UBS downgrades Citizens on revenue headwinds, Wells new top pick 01/11/21 Piper Sandler Citi price target raised to $85 from $68 at Piper Sandler 01/11/21 BofA BofA US 1 List changes 01/06/21 Deutsche Bank Citi price target raised to $58 from $50 at Deutsche Bank C Citi $64.69 / -4.34 (-6.29%) 12:00 Today Citi sees FY21 revenue down mid-to-high single digits, consensus $70.04B 11:56 Today Citi sees FY21 decline in net interest revenues $1B-$2B 08:05 Today Citi reports Q4 EPS $2.08, consensus $1.34 01/14/21 Notable companies reporting before tomorrow's open C Citi $64.69 / -4.34 (-6.29%) 01/11/21 JPMorgan, Citi to halt all PAC donations, WSJ reports 12/31/20 M&A activity rebounded into year-end to finish 2020 down just 5%, FT says 12/22/20 Tech companies win as SEC permits direct IPOs for cash raise, Bloomberg says 12/04/20 Citi scales back staff in New York-area offices, Bloomberg reports C Citi $64.69 / -4.34 (-6.29%) 12:10 Today Fly Intel: Wall Street's top stories at midday 09:48 Today The Intersection: Crypto and Wall Street This Week 11/18/20 Fly Intel: Wall Street's top stories for Wednesday 10/22/20 Tesla upgrades, Peloton downgrade among today's top calls on Wall Street 02/24/21 22nd Annual Virtual Financial Services Forum 11:30 Today Citi - C C Citi $64.69 / -4.34 (-6.29%) 12/11/20 Citi put volume heavy and directionally bearish 11/09/20 Citi call volume above normal and directionally bullish 10/26/20 Citi call volume above normal and directionally bullish 10/14/20 Notable open interest changes for October 14th
Recommendations	Partners Group price target raised to CHF 1,170 from CHF 1,110 at JPMorgan » 12:20 01/15/21 01/15 12:20 01/15/21 12:20 PGPHF Partners Group $0.00 / + (+0.00%) JPMorgan analyst Gurjit… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Events PGPHF Partners Group $0.00 / + (+0.00%) 12/10/20 JPMorgan Partners Group price target raised to CHF 1,110 from CHF 1,000 at JPMorgan 11/24/20 Morgan Stanley Partners Group price target raised to CHF 1,108 from CHF 978 at Morgan Stanley 10/28/20 Societe Generale Partners Group initiated with a Hold at Societe Generale 07/15/20 Kepler Cheuvreux Partners Group downgraded to Hold from Buy at Kepler Cheuvreux 02/24/21 22nd Annual Virtual Financial Services Forum
Recommendations	OMV AG price target raised to EUR 44 from EUR 40 at JPMorgan » 12:19 01/15/21 01/15 12:19 01/15/21 12:19 OMVKY OMV AG $0.00 / + (+0.00%) JPMorgan analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research OMVKY OMV AG $0.00 / + (+0.00%) 12/15/20 H2Accelerate participants collaborate for hydrogen trucking roll-out OMVKY OMV AG $0.00 / + (+0.00%) 01/14/21 Societe Generale Societe Generale downgrades three EU oil & gas names after strong performances 01/11/21 Morgan Stanley OMV AG price target raised to EUR 44 from EUR 36.70 at Morgan Stanley 12/09/20 Berenberg OMV AG price target raised to EUR 38 from EUR 34 at Berenberg 12/07/20 Morgan Stanley OMV AG upgraded to Overweight from Equal Weight at Morgan Stanley
Recommendations	Neste price target raised to EUR 55 from EUR 52 at JPMorgan » 12:19 01/15/21 01/15 12:19 01/15/21 12:19 NTOIY Neste $0.00 / + (+0.00%) JPMorgan analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research NTOIY Neste $0.00 / + (+0.00%) 11/03/20 Bunge to sell Rotterdam facility to Neste for EUR 258M in cash NTOIY Neste $0.00 / + (+0.00%) 01/08/21 Redburn Neste downgraded to Neutral from Buy at Redburn 12/02/20 JPMorgan Neste price target raised to EUR 52 from EUR 38 at JPMorgan 12/02/20 UBS Neste price target raised to EUR 54 from EUR 37 at UBS 11/16/20 RBC Capital Neste downgraded to Sector Perform from Outperform at RBC Capital

Recommendations	LondonMetric price target raised to 230 GBp from 220 GBp at JPMorgan » 12:19 01/15/21 01/15 12:19 01/15/21 12:19 LNSPF LondonMetric $0.00 / + (+0.00%) JPMorgan analyst Vanessa… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research LNSPF LondonMetric $0.00 / + (+0.00%) 12/08/20 RBC Capital LondonMetric price target raised to 215 GBp from 205 GBp at RBC Capital 11/23/20 Barclays LondonMetric price target raised to 250 GBp from 235 GBp at Barclays 07/16/20 Jefferies LondonMetric price target raised to 248 GBp from 237 GBp at Jefferies 06/22/20 Barclays LondonMetric price target raised to 235 GBp from 210 GBp at Barclays
Recommendations	Land Securities price target raised to 800 GBp from 650 GBp at JPMorgan » 12:18 01/15/21 01/15 12:18 01/15/21 12:18 LDSCY Land Securities $0.00 / + (+0.00%) JPMorgan analyst Neil… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research LDSCY Land Securities $0.00 / + (+0.00%) 01/05/21 Morgan Stanley Land Securities downgraded to Underweight from Equal Weight at Morgan Stanley 12/09/20 Jefferies Land Securities price target raised to 785 GBp from 710 GBp at Jefferies 09/03/20 Morgan Stanley Land Securities downgraded to Equal Weight from Overweight at Morgan Stanley
Recommendations	Equinor price target raised to NOK 190 from NOK 180 at JPMorgan » 12:17 01/15/21 01/15 12:17 01/15/21 12:17 EQNR Equinor $19.39 / -0.325 (-1.65%) JPMorgan analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research EQNR Equinor $19.39 / -0.325 (-1.65%) 12/15/20 KNOT Offshore Partners announces acquisition of Tove Knutsen shuttle tanker 11/18/20 Norsk Hydro, Panasonic and Equinor sign MOU to explore European battery business 10/19/20 TechnipFMC awarded EPC contract by Equinor for Breidablikk Pipelay 10/14/20 Equinor, Microsoft sign MoU to collaborate on Northern Lights project EQNR Equinor $19.39 / -0.325 (-1.65%) 01/14/21 Societe Generale Societe Generale downgrades three EU oil & gas names after strong performances 01/14/21 Societe Generale Equinor downgraded to Hold from Buy at Societe Generale 01/13/21 Credit Suisse Equinor price target raised to NOK 220 from NOK 205 at Credit Suisse 01/11/21 Morgan Stanley Equinor price target raised to NOK 175 from NOK 137 at Morgan Stanley
Recommendations	Eni SpA price target raised to EUR 9 from EUR 8.50 at JPMorgan » 12:17 01/15/21 01/15 12:17 01/15/21 12:17 E Eni SpA $21.33 / -0.78 (-3.53%) JPMorgan analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research E Eni SpA $21.33 / -0.78 (-3.53%) 01/14/21 Societe Generale Societe Generale downgrades three EU oil & gas names after strong performances 01/13/21 Credit Suisse Eni SpA price target raised to EUR 10 from EUR 9.20 at Credit Suisse 01/11/21 Morgan Stanley Eni SpA price target raised to EUR 8.20 from EUR 6 at Morgan Stanley 12/09/20 Berenberg Eni SpA price target raised to EUR 9 from EUR 7.60 at Berenberg
Technical Analysis	NASDAQ market internals summary » 12:17 01/15/21 01/15 12:17 01/15/21 12:17 $NSD NASDAQ Market Internals $0.00 / + (+0.00%) Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Technical Analysis $NSD NASDAQ Market Internals $0.00 / + (+0.00%) 11:17 Today NASDAQ market internals summary 10:17 Today NASDAQ market internals summary 01/14/21 NASDAQ market internals summary 01/14/21 NASDAQ market internals summary

Events

Earnings calls, analyst events, roadshows and more

MARA
Today at 13:00

Marathon Patent Group, Inc. Firm Sponsored Meetings

Las Vegas, NV
FPRX
Today at 16:30

Five Prime - FPRX Conference Calls
ZYME
Today at 17:00

Zymeworks - ZYME Conference Calls
MDT ...
Tomorrow at 00:00

2021 NANS Virtual Meeting Conferences

Virtual Meeting
Tomorrow at 00:00

ASCO-GI: Gastrointestinal Cancers Virtual Symposium Conferences

Virtual Symposium
HDB
Tomorrow at 06:30

HDFC Bank - HDB Conference Calls
2021-01-17 at 00:00

ASCO-GI: Gastrointestinal Cancers Virtual Symposium Conferences

Virtual Symposium
2021-01-18 at 00:00

Thailand C-Suite Virtual Corporate Day Conferences

Virtual Conference
LUMO
2021-01-18 at 00:00

Lumos Pharma Firm Sponsored Meetings

Virtual Meeting
2021-01-18 at 00:00

Biotechnology Industry Meetings

Virtual Meeting

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	QLI X QLI Qilian International IPO Managers: Univest Securities, Loop Capital & Alexander Capital Priced at: $5.00 5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MDGS X MDGS Medigus Secondary Managers: Aegis Priced at: $2.30 3.66M Shares O X O Realty Income Spot Secondary Managers: BofA, Morgan Stanley, Wells Fargo & Citi Priced at: $57.05 10.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PSTL X PSTL Postal Realty Trust Spot Secondary Managers: Jefferies, Stifel, BMO Capital & Janney Montgomery Scott Priced at: $15.25 3.25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	ALXO X ALXO ALX Oncology Block Trade Managers: Jefferies Priced at: $82.00 250K Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial IMAB X IMAB I-MAB Block Trade Managers: Jefferies Priced at: $53.00 642K Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AFRM X AFRM Affirm IPO Managers: Morgan Stanley, Goldman Sachs & Allen & Co., RBC Capital, Credit Suisse, Barclays, Truist, SIEB, Deutsche Bank Priced at: $49.00 24.6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MSGM X MSGM Motorsport Games IPO Managers: Canaccord & Benchmark Priced at: $20.00 3M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HCDI X HCDI Harbor Custom Development Secondary Managers: ThinkEquity Priced at: $3.00 8M Shares ZM X ZM Zoom Video Secondary Managers: JPMorgan Priced at: $340.00 5.1M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AFMD X AFMD Affimed N.V. Spot Secondary Managers: Jefferies, SVB Leerink & Credit Suisse Priced at: $6.00 16.667M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RILY X RILY B. Riley Financial Spot Secondary Managers: B. Riley Securities Priced at: $46.00 1.229M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	POSH X POSH Poshmark IPO Managers: Morgan Stanley, Goldman Sachs & Barclays, Stifel, William Blair, Raymond James, Cowen, JMP Securities Priced at: $42.00 6.6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial WOOF X WOOF Petco IPO Managers: Goldman Sachs & BofA, Citi, Evercore ISI, Credit Suisse, UBS, Wells Fargo, Baird, Guggenheim, AmeriVet, CL King, R. Seelaus, Ramirez, SIEB Priced at: $18.00 48M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LMND X LMND Lemonade Secondary Managers: Goldman Sachs, Morgan Stanley, Allen & Co. & Barclays Priced at: $165.00 4.524M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PRVB X PRVB Provention Bio Secondary Managers: SVB Leerink & Cantor Fitzgerald Priced at: $16.00 6.25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RPAY X RPAY Repay Holdings Secondary Managers: Credit Suisse & Barclays, Citi, Truist Priced at: $24.00 5.43M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VNT X VNT Vontier Secondary Managers: Goldman Sachs, Citi & Evercore ISI, JPMorgan, Morgan Stanley, Credit Suisse, UBS, Baird Priced at: $33.50 33.507M Shares ALDX X ALDX Aldeyra Spot Secondary Managers: Jefferies & SVB Leerink Priced at: $9.50 6.842M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EVOK X EVOK Evoke Pharma Spot Secondary Managers: Laidlaw Priced at: $2.50 5M Shares
Thurs	DRVN X DRVN Driven Brands IPO Managers: Morgan Stanley, BofA, Goldman Sachs, JPMorgan & Barclays, Credit Suisse, Baird, Piper Sandler, William Blair Priced at: $22.00 31.8M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KUKE X KUKE Kuke Music IPO Managers: Deutsche Bank, Tigress Financial, AMTD & China International, Valuable Capital Priced at: $10.00 5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PLTK X PLTK Playtika IPO Managers: Morgan Stanley, Credit Suisse, Citi, Goldman Sachs, UBS & BofA, Baird, Cowen, Stifel, Wedbush Priced at: $27.00 69.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AMWL X AMWL Amwell Secondary Managers: Morgan Stanley, Goldman Sachs, Piper Sandler & UBS, Credit Suisse, Cowen, Berenberg Priced at: $27.50 11.281M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ITP X ITP IT Tech Packaging Secondary Managers: Maxim Priced at: $.55 26.182M Shares EAF X EAF GrafTech Spot Secondary Managers: Morgan Stanley Priced at: $10.90 20M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LTRN X LTRN Lantern Pharma Spot Secondary Managers: ThinkEquity Priced at: $14.00 4.28M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Eiger announces oral presentation of Phase 2 LIFT results

TODAY'S FREE FLY STORIES

Get Full Fly Access